SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-13-000213
Filing Date
2013-01-04
Accepted
2013-01-14 09:56:24
Documents
1
Effectiveness Date
2013-01-04

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-13-000213.paper CERTNAS 294
  Scanned paper document scanned.pdf   47134
  Complete submission text file 9999999997-13-000213.txt   1308
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: CERTNAS | Act: 34 | File No.: 001-35776 | Film No.: 13000092
SIC: 2834 Pharmaceutical Preparations